280Bio | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Trial results

27 February 2024

Revolution pushes home its pan-KRAS advantage

Not long after starting phase 1, RMC-6236 could be in pivotal trials this year.

Subscribe to 280Bio